ProQR Therapeutics N.V. - Ordinary Shares (NQ:PRQR)

1.330 -0.040 (-2.92%)

Delayed Quote Updated: 4:00 PM EDT, Oct 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ProQR Therapeutics N.V. - Ordinary Shares

< Previous 1 2 3 4 5 Next >

Where ProQR Therapeutics Stands With Analysts ↗

February 14, 2022

Analysts have provided the following ratings for ProQR Therapeutics (NASDAQ:PRQR) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

February 14, 2022

During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks Noteable 52-Week Lows And Highs: SAP (...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022 ↗

February 14, 2022

Upgrades According to Mizuho, the prior rating for Murphy Oil Corp (NYSE:MUR) was changed from Neutral to Buy. In the fourth quarter, Murphy Oil showed an EPS of $0.40,...

Via Benzinga

78 Biggest Movers From Friday ↗

February 14, 2022

Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education...

Via Benzinga

Mid-Afternoon Market Update: US Stocks Extend Losses; Dow Tumbles 450 Points ↗

February 11, 2022

US stocks extended losses toward the end of trading session, with the Dow Jones tumbling 450 points on Friday.

Via Benzinga

52 Weeks High And Low Article ↗

February 11, 2022

On Friday, 106 companies reached new 52-week lows. Things to Consider About Today's 52-Week Lows: Air Products & Chemicals (NYSE:APD) is the largest company...

Via Benzinga

Mid-Day Market Update: Nasdaq Drops 100 Points; Bloom Energy Shares Jump ↗

February 11, 2022

The Nasdaq turned lower during the mid-day session, with the tech-laden index falling 100 points on Friday.

Via Benzinga

41 Stocks Moving In Friday's Mid-Day Session ↗

February 11, 2022

Gainers Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday. Kaival Brands Innovations...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher As Dow Rises Over 100 Points ↗

February 11, 2022

U.S. stocks opened on a strong note on Friday, after recording sharp losses in the previous session.

Via Benzinga

The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO ↗

February 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-...

Via Benzinga

ProQR Shares Crater After Disappointing Sepofarsen Data In Inherited Vision Loss Disorder ↗

February 11, 2022

ProQR Therapeutics N.V. (NASDAQ: PRQR) shares are plunging after disappointing data from its pivotal Phase 2/3 Illuminate trial of sepofarsen for CEP290-mediated...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 01, 2022

Rise and shine, trader! We're starting off another day of investing with a breakdown of the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

16 Stocks Moving in Tuesday's Pre-Market Session ↗

February 01, 2022

Gainers ObsEva SA (NASDAQ: OBSV) rose 22.2% to $1.87 in pre-market trading after the company announced a corporate update, including an increase in share capital on...

Via Benzinga

The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings ↗

November 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Roche's Spark Subsidiary Reports Positive Phase 1/2 Data For Hemophilia...

Via Benzinga

The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More ↗

November 14, 2021

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at...

Via Benzinga

48 Biggest Movers From Yesterday ↗

September 10, 2021

Gainers Rocket Lab USA, Inc. (NASDAQ: RKLB) jumped 37.3% to settle at $20.72. Rocket Lab reported 1H sales of $29.5 million and announced it has been awarded a contract to deploy...

Via Benzinga

Here's Why ProQR Stock Surged on Thursday ↗

September 09, 2021

A new collaboration deal with Eli Lilly could be worth up to $1.3 billion.

Via The Motley Fool

Why ProQR Therapeutics's Stock Is Trading Higher Today ↗

September 09, 2021

ProQR Therapeutics's (NASDAQ:PRQR) shares are trading higher after the company announced Axiomer RNA editing licensing and research collaboration with Lilly. ProQR...

Via Benzinga

35 Stocks Moving In Thursday's Mid-Day Session ↗

September 09, 2021

Gainers Gevo, Inc. (NASDAQ: GEVO) shares climbed 36.6% to $7.91. Chevron and Gevo announced intent to pursue sustainable aviation fuel investment. Offerpad Solutions Inc (NYSE:...

Via Benzinga

Eli Lilly Inks Another RNA Collab, This Time With ProQR ↗

September 09, 2021

Eli Lilly And Co (NYSE: LLY) is doubling down on RNA research as it pens another pact with a quiet RNA editing player focused on neuroscience, ProQR...

Via Benzinga

21 Stocks Moving in Thursday's Pre-Market Session ↗

September 09, 2021

Gainers Cardiff Oncology, Inc. (NASDAQ: CRDF) rose 17.3% to $8.27 in pre-market trading after the company announced new data from its Phase 1b/2 trial in KRAS-mutated metastatic...

Via Benzinga

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗

September 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

Via Benzinga

ProQR Therapeutics Stock Is Trading Higher On Antisense Oligonucleotide Development Pact ↗

May 04, 2021

Yarrow Biotechnology Inc, a newly created company by RTW Investments LP, has in-licensed exclusive rights to ProQR Therapeutics N.V.'s (NASDAQ: ...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 04, 2021

Gainers BioLine Rx (NASDAQ:BLRX) shares moved upwards by 65.2% to $5.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $226.7...

Via Benzinga

An End to This Rare Syndrome Could Be an Opportunity for Investors ↗

April 07, 2021

A rare genetic disease that causes combined blindness and deafness may have a novel treatment in line after positive phase 1/2 trial results last month.

Via The Motley Fool

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.